Ashok Leyland. Source: Company Data; PL Research

Similar documents
TVS Motors. Source: Company Data; PL Research

Maruti Suzuki. Source: Company Data; PL Research

Eicher Motors. Continues to ride high! Accumulate. Source: Company Data; PL Research

Maruti Suzuki. In a league of its own ; Buy. Source: Company Data; PL Research

Mahindra & Mahindra. Source: Company Data; PL Research

Maruti Suzuki. Source: Company Data; PL Research

Bharat Forge. Exports remain subdued, outlook better. Source: Company Data; PL Research

Tata Motors. Source: Company Data; PL Research

SpiceJet. Healthy operating performance in Q2. Source: Company Data; PL Research

Bharat Forge. Growth on all fronts; Accumulate. Source: Company Data; PL Research

Cummins India. Growth/margin bottoming. Source: Company Data; PL Research

Crompton Greaves. Looking to exit overseas Power segment! Source: Company Data; PL Research

Tata Motors. Source: Company Data; PL Research

Siemens. Railways and T&D driving inflows. Source: Company Data; PL Research

Thermax. Source: Company Data; PL Research

Cummins India. Source: Company Data; PL Research

Eicher Motors. Source: Company Data; PL Research

Coal India. Source: Company Data; PL Research

Asian Paints. Source: Company Data; PL Research

Bharat Petroleum Corporation

Coal India. Source: Company Data; PL Research

Mphasis. Increased confidence on margins. Source: Company Data; PL Research

Asian Paints. Source: Company Data; PL Research

Source: Company Data; PL Research

Coal India. Source: Company Data; PL Research

Allcargo Logistics. Source: Company Data; PL Research

Coal India. Source: Company Data; PL Research

Britannia Industries

JK Lakshmi Cement. Source: Company Data; PL Research

Hindustan Zinc. Source: Company Data; PL Research

Indraprastha Gas. Growth traction continues. Source: Company Data; PL Research

Hindalco Industries. Source: Company Data; PL Research

Persistent Systems. Growth led by Enterprise Retain BUY. Source: Company Data; PL Research

Jindal Steel & Power

Bharat Electronics. Best defence play. Source: Company Data; PL Research

Hindustan Zinc. Source: Company Data; PL Research

Larsen & Toubro. Decent performance! Source: Company Data; PL Research

Crompton Greaves Consumer Electricals

Cadila Healthcare. Source: Company Data; PL Research

NIIT Technologies. Strong growth in core services. Source: Company Data; PL Research

Dr. Lal PathLabs. Source: Company Data; PL Research

Navneet Education. ILL loss hurts consolidated earnings growth. Source: Company Data; PL Research

Reliance Industries. Impressive performance. Source: Company Data; PL Research

Aurobindo Pharma. Source: Company Data; PL Research

Ultratech Cement. Source: Company Data; PL Research

Tata Motors. Turnaround 2.0, Fit for future; BUY. Source: Company Data; PL Research

Tech Mahindra. Source: Company Data; PL Research

Va Tech Wabag. On track for a strong H2FY16. Source: Company Data; PL Research

Hindustan Unilever. In the Pink of Health ; Accumulate. Source: Company Data; PL Research

Sonata Software. Strong growth, reasonable valuations. Source: Company Data; PL Research

Source: Company Data; PL Research

Cummins India. Focusing on growth in core segments. Source: Company Data; PL Research

Mphasis. Source: Company Data; PL Research

HDFC Standard Life Insurance

S Chand and Company. TP of Rs679 (implying PER of 20x FY19E earnings) Source: Company Data; PL Research

Glenmark Pharmaceuticals

Indraprastha Gas. Source: Company Data; PL Research

Jindal Steel & Power

Crompton Greaves Consumer Electricals

Maruti Suzuki (MSIL IN)

Larsen & Toubro. Source: Company Data; PL Research

Need to pull up the socks. Source: Company Data; PL Research

Tata Steel. Source: Company Data; PL Research

Colgate Palmolive. Source: Company Data; PL Research

ICICI Prudential Life Insurance

Cig volumes surprise. Source: Company Data; PL Research

Source: Company Data; PL Research

TVS Motors (TVSL IN)

Bharat Forge. Strong traction in exports. (our estimate Rs730m). Source: Company Data; PL Research

LIC Housing Finance. Source: Company Data; PL Research

Dabur India. Source: Company Data; PL Research

Britannia Industries

Glenmark Pharmaceuticals

Aurobindo Pharma. Source: Company Data; PL Research

Bayer Cropscience (BYRCS IN)

Cadila Healthcare. Source: Company Data; PL Research

Capital First. Continuing to grow strong. Source: Company Data; PL Research

BHEL.BO BHEL IN. Structural story remains weak. Q1FY19 Result Update. Rating: REDUCE CMP: Rs72 TP: Rs73. July 25, 2018

Dr. Reddy's Laboratories

FY20E FY21E FY20E FY21E

Cadila Healthcare. Source: Company Data; PL Research

NIIT Technologies. Source: Company Data; PL Research

Crompton Greaves Consumer Electricals (CROMPTON IN) Rating: BUY CMP: Rs195 TP: Rs276

VRL Logistics. Steady show in tough environment. Source: Company Data; PL Research

Dabur India. Steady recovery in place; Accumulate. Source: Company Data; PL Research

Punjab National Bank

Hindustan Zinc. Strong show, H2 to be stronger than H1. Source: Company Data; PL Research

Dr. Reddy's Laboratories

Dabur India. Worst is over; Accumulate. Source: Company Data; PL Research

SBI Life Insurance Company (SBILIFE IN ) Rating: BUY CMP: Rs673 TP: Rs840

Dabur India. Share gains power growth, Accumulate. Source: Company Data; PL Research

Pantaloon Retail India

GMR Infrastructure. Airport revenues on a thaw, Power awaiting its turn. Q3FY13 Result Update

Gujarat State Fertilisers & Chemicals

Apollo Tyres. Profitability likely to improve. Source: Company Data; PL Research

Larsen & Toubro (LT IN)

Mindtree. Source: Company Data; PL Research.

LIC Housing Finance. Stable performance. Source: Company Data; PL Research

Reliance Infrastructure

NIIT Technologies. Source: Company Data; PL Research

Transcription:

Short term headwinds, structural story intact; Accumulate November 09, 2017 Saksham Kaushal sakshamkaushal@plindia.com +91 22 66322235 Poorvi Banka poorvibanka@plindia.com +91 22 66322426 Rating Accumulate Price Rs115 Target Price Rs125 Implied Upside 8.7% Sensex 33,251 Nifty 10,309 (Prices as on November 09, 2017) Trading data Market Cap. (Rs bn) 328.4 Shares o/s (m) 2,845.9 3M Avg. Daily value (Rs m) 1299.9 Major shareholders Promoters 51.37% Foreign 23.41% Domestic Inst. 10.45% Public & Other 14.77% Stock Performance (%) 1M 6M 12M Absolute (7.0) 39.2 26.3 Relative (11.4) 28.1 4.2 How we differ from Consensus EPS (Rs) PL Cons. % Diff. 2019 5.1 6.1 (16.4) 2020 6.5 7.2 (9.3) Price Performance (RIC: ASOK.BO, BB: AL IN) (Rs) 140 120 100 80 60 40 20 0 Nov 16 Jan 17 Mar 17 Source: Bloomberg May 17 Jul 17 Sep 17 Nov 17 Ashok Leyland s (AL) Q2FY18 operating performance slightly missed estimates with EBITDA margin lowering 150bps YoY (however, up 290bps QoQ) to 10.1% (PLe: 11%). Operating margins for the quarter were adversely impacted on account of (a) heavy discounting by competitors, (b) aggressive pricing for exports in order to push the unsold BS III inventory (c) loss of some excise duty benefits (~5%) from the Pantnagar plant owing to GST implementation. Overall volume growth for AL in Q2 was ~23% YoY and realisations grew 6.7% YoY, leading to a strong revenue growth of ~31% YoY to Rs60.5bn (PLe: Rs62bn). M&HCV growth during the quarter was ~24% YoY where LCVs grew ~18% YoY. While the management expects the M&HCV industry to grow 5 10% YoY in the current fiscal, we expect ~5% M&HCV volume growth for AL in FY18e. The company also booked a minor one off loss in the quarter adjusting for which, AL s profit in Q2FY18 was Rs3.4bn, up 17% YoY (however, marginally lower than expected). With strong recovery in volumes in Q2 and further recovery expected in Q3 (while Q4FY18 may be impacted by the high base on account of pre buying in Q4FY17), AL should register decent growth in the current fiscal. The company is however, likely to report further improved performance in FY19/20, on the back of strict overloading restrictions, better freight availability, increased government focus on infrastructure spend and pre buying ahead of BS VI implementation in 2020. In the longer term, management also expects significantly higher contribution from Non India CV segments, i.e. defence and exports. With the CV cycle unlikely to have peaked, we believe that volume growth should recover in H2FY18E. We maintain an Accumulate rating on the stock with a target price of Rs125 (based on an 11x Sep19E EV/EBITDA). Key financials (Y/e March) 2017 2018E 2019E 2020E Revenues L s Q2FY18 (Rs m) vehicle sales grew a 200,187 strong 22.6% 220,401 YoY to ~41K 251,520 units. Of 294,171 this, Growth M&HCVs (%) surged ~24% YoY (up a robust 5.7 58% QoQ) while 10.1 LCVs were 14.1 higher ~18% 17.0 EBITDA YoY. (Rs m) 22,025 22,689 26,865 32,726 PAT (Rs m) 15,585 12,511 14,450 Contd...2 18,411 EPS (Rs) 5.5 4.4 5.1 6.5 Growth (%) 29.9 (19.7) 15.5 27.4 Net DPS (Rs) 1.6 1.8 2.0 2.3 Profitability & Valuation 2017 2018E 2019E 2020E EBITDA margin (%) 11.0 10.3 10.7 11.1 RoE (%) 27.0 19.4 20.2 22.8 RoCE (%) 20.7 15.6 16.7 19.1 EV / sales (x) 1.7 1.5 1.2 1.0 EV / EBITDA (x) 15.5 14.3 11.5 9.0 PE (x) 21.1 26.2 22.7 17.8 P / BV (x) 5.4 4.8 4.4 3.8 Net dividend yield (%) 1.4 1.5 1.7 1.9 Source: Company Data; PL Research Q2FY18 Result Update Prabhudas Lilladher Pvt. Ltd. and/or its associates (the 'Firm') does and/or seeks to do business with companies covered in its research reports. As a result investors should be aware that the Firm may have a conflict of interest that could affect the objectivity of the report. Investors should consider this report as only a single factor in making their investment decision. Please refer to important disclosures and disclaimers at the end of the report

With volumes growth of ~23% YoY and realisations improving 6.7% YoY, AL posted a strong 30.8% YoY rise in revenues to Rs60.5bn (PLe: Rs62bn). Operationally, the performance was lower than expected as EBITDA margin lowered ~150bps YoY (however, was up 290bps QoQ) to 10.1% (PLe: 11%). EBITDA growth for the quarter was at 14% YoY to Rs6.12bn. EBITDA per vehicle was however, dipped 7% YoY (up ~39% QoQ). The decline in EBITDA margin was mainly due to lower gross margins, down 240bps YoY and 180bps QoQ. Staff costs were stable YoY but lower 230bps QoQ while other expenses as a % of sales were down 190bps YoY and 230bps QoQ respectively. Gross profit per vehicle was lower ~5% YoY in Q2FY18. The company also booked a one time loss amounting to Rs26mn on account of swap contracts, adjusting for which, the profit was at ~Rs3.4bn, up 17% YoY. Conference call highlights The management expects the M&HCV industry to grow by 5 10% YoY in the current fiscal where AL is also expected to grow in line with the industry (we are factoring in ~7% YoY growth in FY18e). Pantnagar plant excise benefits (expiring in Mar 20) which were ~13% before GST have now gone down to 8.2% (decision regarding the SGST portion forming 42% still pending). Average discount per truck for the company over Q2FY18 was ~Rs350K against ~Rs320K in Q1FY18, while other players have given discounts upto Rs450K in the quarter. The company has taken a 1% price hike in Oct 17 where industry discounts seem to continue in Q3 too. Exports for the quarter were mainly to Sri Lanka, Bangladesh and UAE, at low margins in order to push the unsold BS III inventory (75% cleared now). The LCV segment earned ~8 9% EBITDA margins in the quarter and the company has planned to launch 6 7 new products in the category over the next 12 months. Revenue from spare parts for the quarter stood at ~Rs3bn again. Capex guidance over the next 3 years stands at ~Rs5 6bn per year, mainly on account of debottlenecking of capacities, new launches, etc. Hinduja Foundries was EBITDA positive for the quarter, earning an operating margin of ~8%. November 09, 2017 2

Exhibit 1: Q2FY18 Result Overview (Rs m) Y/e March Q2FY18 Q2FY17 YoY gr. (%) Q1FY18 H1FY18 H1FY17 YoY gr. (%) Net Revenues 60,469 46,224 30.8 42,378 102,847 88,812 15.8 Raw Materials 43,074 31,337 37.5 29,423 72,497 60,642 19.5 % of Net Sales 71.2 67.8 69.4 70.5 68.3 Personnel 4,825 3,692 30.7 4,376 9,201 7,273 26.5 % of Net Sales 8.0 8.0 10.3 8.9 8.2 Manufacturing & Other Exp 6,452 5,830 10.7 5,516 11,968 10,770 11.1 % of Net Sales 10.7 12.6 13.0 11.6 12.1 Total Expenditure 54,351 40,859 33.0 39,315 93,666 78,685 19.0 EBITDA 6,118 5,365 14.0 3,063 9,181 10,128 (9.3) EBITDA Margin (%) 10.1 11.6 7.2 8.9 11.4 Depreciation 1,411 1,261 11.9 1,321 2,733 2,471 10.6 EBIT 4,707 4,104 14.7 1,741 6,448 7,657 (15.8) Interest Expenses 410 339 20.9 366 777 677 14.6 Non operating income 557 316 76.1 384 941 759 23.9 Extraordinary Expenses 26 NA 152 179 NA Extraordinary Income 66 NA 562 NA PBT 4,827 4,146 1,607 6,433 8,301 (22.5) Tax Total 1,484 1,202 23.4 492 1,976 2,449 (19.3) Tax Rate (%) Total 30.7 29.0 6.0 30.6 30.7 29.5 4.1 Reported PAT 3,343 2,944 13.5 1,114 4,457 5,852 (23.8) Adj. PAT 3,369 2,885 16.8 1,252 4,618 5,346 (13.6) Source: Company Data, PL Research Exhibit 2: Operating Metrics (Rs m) Y/e March Q2FY18 Q2FY17 YoY gr. (%) Q1FY18 H1FY18 H1FY17 YoY gr. (%) Sales Volume (nos) 40,985 33,440 22.6 28,494 69,479 64,605 7.5 Net Realisation/Vehicle 1,475,391 1,382,298 6.7 1,487,254 1,480,257 1,374,699 7.7 Material cost / vehicle 1,050,964 937,102 12.2 1,032,596 1,043,431 938,655 11.2 Gross Profit / vehicle 424,427 445,196 (4.7) 454,658 436,825 436,044 0.2 Employee cost /vehicle 117,723 110,408 6.6 153,589 132,432 112,582 17.6 Other expenses / vehicle 157,430 174,355 (9.7) 193,583 172,257 166,701 3.3 EBITDA/vehicle 149,273 160,433 (7.0) 107,487 132,136 156,762 (15.7) Net Profit/vehicle 82,201 86,274 (4.7) 43,923 66,465 82,746 (19.7) Source: Company Data, PL Research November 09, 2017 3

Income Statement (Rs m) Net Revenue 200,187 220,401 251,520 294,171 Raw Material Expenses 139,573 156,431 175,935 204,229 Gross Profit 60,614 63,970 75,585 89,942 Employee Cost 15,309 16,530 18,864 21,769 Other Expenses 23,279 24,751 29,855 35,448 EBITDA 22,025 22,689 26,865 32,726 Depr. & Amortization 5,179 5,680 7,014 7,464 Net Interest 1,554 1,287 1,555 1,609 Other Income (1,992) 1,534 1,634 1,740 Profit before Tax 13,301 17,257 19,931 25,394 Total Tax 1,070 4,746 5,481 6,983 Profit after Tax 12,231 12,511 14,450 18,411 Ex Od items / Min. Int. (3,354) Adj. PAT 15,585 12,511 14,450 18,411 Avg. Shares O/S (m) 2,845.9 2,845.9 2,845.9 2,845.9 EPS (Rs.) 5.5 4.4 5.1 6.5 Cash Flow Abstract (Rs m) C/F from Operations 19,134 31,719 25,713 30,110 C/F from Investing (17,252) (9,000) (4,000) (6,000) C/F from Financing (8,695) (6,267) (7,247) (8,012) Inc. / Dec. in Cash (6,812) 16,452 14,467 16,098 Opening Cash 15,931 9,120 25,571 40,038 Closing Cash 9,119 25,571 40,038 56,136 FCFF 17,769 20,887 20,317 25,805 FCFE 15,068 20,887 20,317 25,805 Key Financial Metrics Growth Revenue (%) 5.7 10.1 14.1 17.0 EBITDA (%) (2.3) 3.0 18.4 21.8 PAT (%) 29.9 (19.7) 15.5 27.4 EPS (%) 29.9 (19.7) 15.5 27.4 Profitability EBITDA Margin (%) 11.0 10.3 10.7 11.1 PAT Margin (%) 7.8 5.7 5.7 6.3 RoCE (%) 20.7 15.6 16.7 19.1 RoE (%) 27.0 19.4 20.2 22.8 Balance Sheet Net Debt : Equity 0.2 (0.1) (0.2) (0.4) Net Wrkng Cap. (days) 1 1 (1) Valuation PER (x) 21.1 26.2 22.7 17.8 P / B (x) 5.4 4.8 4.4 3.8 EV / EBITDA (x) 15.5 14.3 11.5 9.0 EV / Sales (x) 1.7 1.5 1.2 1.0 Earnings Quality Eff. Tax Rate 8.0 27.5 27.5 27.5 Other Inc / PBT 8.2 8.9 8.2 6.9 Eff. Depr. Rate (%) 8.8 8.4 9.7 9.7 FCFE / PAT 96.7 166.9 140.6 140.2 Source: Company Data, PL Research. Balance Sheet Abstract (Rs m) Shareholder's Funds 61,261 67,778 75,377 86,081 Total Debt 21,449 21,449 21,449 21,449 Other Liabilities 1,269 2,769 2,769 2,769 Total Liabilities 83,978 91,995 99,595 110,298 Net Fixed Assets 51,284 53,087 51,073 47,609 Goodwill 483 Investments 28,789 30,789 29,789 31,789 Net Current Assets 3,423 8,120 18,733 30,900 Cash & Equivalents 9,120 25,571 40,038 56,136 Other Current Assets 48,319 54,203 61,399 69,833 Current Liabilities 54,016 71,654 82,704 95,068 Other Assets Total Assets 83,979 91,995 99,595 110,298 Quarterly Financials (Rs m) Y/e March Q3FY17 Q4FY17 Q1FY18 Q2FY18 Net Revenue 45,163 66,179 42,378 60,469 EBITDA 4,541 7,299 3,063 6,118 % of revenue 10.1 11.0 7.2 10.1 Depr. & Amortization 1,313 1,395 1,321 1,411 Net Interest 453 423 366 410 Other Income 258 404 384 557 Profit before Tax 2,395 5,855 1,607 4,827 Total Tax 778 1,093 484 1,484 Profit after Tax 1,617 4,762 1,123 3,343 Adj. PAT 2,190 4,788 1,260 3,366 Key Operating Metrics Passenger M&HCV sales (units) 22,602 22,381 24,269 26,667 Goods M&HCV sales (units) 90,690 96,022 104,238 117,009 Dost volumes (units) 31,441 35,162 41,468 47,282 Other LCV sales (units) 333 1,640 2,111 2,558 Total volume (units) 145,066 155,205 172,085 193,517 Realisation per vehicle (Rs) 1,352,495 1,394,075 1,437,178 1,495,961 Gross margin per vehicle (Rs) 417,837 412,168 439,229 464,777 EBITDA per vehicle (Rs) 151,830 146,189 156,117 169,111 Profit per vehicle (Rs) 107,436 80,611 83,969 95,137 Source: Company Data, PL Research. November 09, 2017 4

Prabhudas Lilladher Pvt. Ltd. 3rd Floor, Sadhana House, 570, P. B. Marg, Worli, Mumbai 400 018, India Tel: (91 22) 6632 2222 Fax: (91 22) 6632 2209 Rating Distribution of Research Coverage PL s Recommendation Nomenclature % of Total Coverage 50% 40% 30% 20% 10% 0% 44.5% 39.1% 16.4% 0.0% BUY Accumulate Reduce Sell BUY : Over 15% Outperformance to Sensex over 12 months Accumulate : Outperformance to Sensex over 12 months Reduce : Underperformance to Sensex over 12 months Sell : Over 15% underperformance to Sensex over 12 months Trading Buy : Over 10% absolute upside in 1 month Trading Sell : Over 10% absolute decline in 1 month Not Rated (NR) : No specific call on the stock Under Review (UR) : Rating likely to change shortly DISCLAIMER/DISCLOSURES ANALYST CERTIFICATION We/I, Mr. Saksham Kaushal (BSc Accounting & Finance (Hons.)), Ms. Poorvi Banka (MSc. Finance), Research Analysts, authors and the names subscribed to this report, hereby certify that all of the views expressed in this research report accurately reflect our views about the subject issuer(s) or securities. We also certify that no part of our compensation was, is, or will be directly or indirectly related to the specific recommendation(s) or view(s) in this report. Terms & conditions and other disclosures: Prabhudas Lilladher Pvt. Ltd, Mumbai, India (hereinafter referred to as PL ) is engaged in the business of Stock Broking, Portfolio Manager, Depository Participant and distribution for third party financial products. PL is a subsidiary of Prabhudas Lilladher Advisory Services Pvt Ltd. which has its various subsidiaries engaged in business of commodity broking, investment banking, financial services (margin funding) and distribution of third party financial/other products, details in respect of which are available at www.plindia.com This document has been prepared by the Research Division of PL and is meant for use by the recipient only as information and is not for circulation. This document is not to be reported or copied or made available to others without prior permission of PL. It should not be considered or taken as an offer to sell or a solicitation to buy or sell any security. The information contained in this report has been obtained from sources that are considered to be reliable. However, PL has not independently verified the accuracy or completeness of the same. Neither PL nor any of its affiliates, its directors or its employees accepts any responsibility of whatsoever nature for the information, statements and opinion given, made available or expressed herein or for any omission therein. Recipients of this report should be aware that past performance is not necessarily a guide to future performance and value of investments can go down as well. The suitability or otherwise of any investments will depend upon the recipient's particular circumstances and, in case of doubt, advice should be sought from an independent expert/advisor. Either PL or its affiliates or its directors or its employees or its representatives or its clients or their relatives may have position(s), make market, act as principal or engage in transactions of securities of companies referred to in this report and they may have used the research material prior to publication. PL may from time to time solicit or perform investment banking or other services for any company mentioned in this document. PL is in the process of applying for certificate of registration as Research Analyst under Securities and Exchange Board of India (Research Analysts) Regulations, 2014 PL submits that no material disciplinary action has been taken on us by any Regulatory Authority impacting Equity Research Analysis activities. PL or its research analysts or its associates or his relatives do not have any financial interest in the subject company. PL or its research analysts or its associates or his relatives do not have actual/beneficial ownership of one per cent or more securities of the subject company at the end of the month immediately preceding the date of publication of the research report. PL or its research analysts or its associates or his relatives do not have any material conflict of interest at the time of publication of the research report. PL or its associates might have received compensation from the subject company in the past twelve months. PL or its associates might have managed or co managed public offering of securities for the subject company in the past twelve months or mandated by the subject company for any other assignment in the past twelve months. PL or its associates might have received any compensation for investment banking or merchant banking or brokerage services from the subject company in the past twelve months. PL or its associates might have received any compensation for products or services other than investment banking or merchant banking or brokerage services from the subject company in the past twelve months PL or its associates might have received any compensation or other benefits from the subject company or third party in connection with the research report. PL encourages independence in research report preparation and strives to minimize conflict in preparation of research report. PL or its analysts did not receive any compensation or other benefits from the subject Company or third party in connection with the preparation of the research report. PL or its Research Analysts do not have any material conflict of interest at the time of publication of this report. It is confirmed that Mr. Saksham Kaushal (BSc Accounting & Finance (Hons.)), Ms. Poorvi Banka (MSc. Finance), Research Analysts of this report have not received any compensation from the companies mentioned in the report in the preceding twelve months Compensation of our Research Analysts is not based on any specific merchant banking, investment banking or brokerage service transactions. The Research analysts for this report certifies that all of the views expressed in this report accurately reflect his or her personal views about the subject company or companies and its or their securities, and no part of his or her compensation was, is or will be, directly or indirectly related to specific recommendations or views expressed in this report. The research analysts for this report has not served as an officer, director or employee of the subject company PL or its research analysts have not engaged in market making activity for the subject company Our sales people, traders, and other professionals or affiliates may provide oral or written market commentary or trading strategies to our clients that reflect opinions that are contrary to the opinions expressed herein, and our proprietary trading and investing businesses may make investment decisions that are inconsistent with the recommendations expressed herein. In reviewing these materials, you should be aware that any or all o the foregoing, among other things, may give rise to real or potential conflicts of interest. PL and its associates, their directors and employees may (a) from time to time, have a long or short position in, and buy or sell the securities of the subject company or (b) be engaged in any other transaction involving such securities and earn brokerage or other compensation or act as a market maker in the financial instruments of the subject company or act as an advisor or lender/borrower to the subject company or may have any other potential conflict of interests with respect to any recommendation and other related information and opinions. DISCLAIMER/DISCLOSURES (FOR US CLIENTS) ANALYST CERTIFICATION The research analysts, with respect to each issuer and its securities covered by them in this research report, certify that: All of the views expressed in this research report accurately reflect his or her or their personal views about all of the issuers and their securities; and No part of his or her or their compensation was, is or will be directly related to the specific recommendation or views expressed in this research report Terms & conditions and other disclosures: This research report is a product of Prabhudas Lilladher Pvt. Ltd., which is the employer of the research analyst(s) who has prepared the research report. The research analyst(s) preparing the research report is/are resident outside the United States (U.S.) and are not associated persons of any U.S. regulated broker dealer and therefore the analyst(s) is/are not subject to supervision by a U.S. broker dealer, and is/are not required to satisfy the regulatory licensing requirements of FINRA or required to otherwise comply with U.S. rules or regulations regarding, among other things, communications with a subject company, public appearances and trading securities held by a research analyst account. This report is intended for distribution by Prabhudas Lilladher Pvt. Ltd. only to "Major Institutional Investors" as defined by Rule 15a 6(b)(4) of the U.S. Securities and Exchange Act, 1934 (the Exchange Act) and interpretations thereof by U.S. Securities and Exchange Commission (SEC) in reliance on Rule 15a 6(a)(2). If the recipient of this report is not a Major Institutional Investor as specified above, then it should not act upon this report and return the same to the sender. Further, this report may not be copied, duplicated and/or transmitted onward to any U.S. person, which is not the Major Institutional Investor. In reliance on the exemption from registration provided by Rule 15a 6 of the Exchange Act and interpretations thereof by the SEC in order to conduct certain business with Major Institutional Investors, Prabhudas Lilladher Pvt. Ltd. has entered into an agreement with a U.S. registered broker dealer, Marco Polo Securities Inc. ("Marco Polo"). Transactions in securities discussed in this research report should be effected through Marco Polo or another U.S. registered broker dealer. November 09, 2017 5